Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs

Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs

Source: 
KHN
snippet: 

Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from “biosimilars.” It’s a very different story in Europe.